The True Face of the Pyramid; Physical Activity Level and Cardiovascular Risk in Patients With Breast Cancer
1 other identifier
observational
70
1 country
1
Brief Summary
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Many risk factors are thought to be important in the development of CVD; however, some risk factors can be controlled. Regular physical activity (PA) is recommended for the entire population for the primary prevention of CVD. PA and physical health are also believed to reduce other CVD risk factors such as body mass index, blood pressure and stress. Although oncological outcome is the most important factor for breast cancer survivors, CVD has emerged as an important cause of death among them. In particular, CVD mortality is known to increase 7 years after breast cancer diagnosis, and death due to CVD is more common in older patients than death from cancer. Higher levels of physical activity compared to low levels measured prior to breast cancer diagnosis were associated with statistically significantly lower all-cause mortality among women diagnosed with breast cancer. For breast cancer survivors, increasing PA during and after treatment has been reported to be safe and effective in improving cancer survival, alleviating cancer-related symptoms and improving quality of life. However, there is a lack of evidence regarding the effect of PA on cardiovascular outcomes in long-term breast cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2024
CompletedFirst Submitted
Initial submission to the registry
February 15, 2025
CompletedFirst Posted
Study publicly available on registry
February 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 29, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2025
CompletedDecember 16, 2025
December 1, 2025
10 months
February 15, 2025
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Physical Activity Level
Physical activity level was assessed using a multisensorial PA monitor. The SenseWear Armband (Armband Model MF-SW, BodyMedia, Pittsburgh, USA) was worn on the back of the left-side upper arm over the triceps for at least 7 consecutive days, except for times requiring contact with water, such as bathing and swimming. The monitor estimates energy expenditure using measurements from tri-axial accelerometers and sensors (galvanic skin response, heat flux, and skin temperature). The measured outputs of the SWA is step count
One Year
Cardiovascular Disease Risk Scoring
SCORE2
One Year
Functional exercise capacity
6 minutes walk test
one year
Eligibility Criteria
Study Population: Patients between the ages of 40-80 years who were diagnosed with breast cancer in Hacettepe University Hospital, Department of Internal Medicine, Department of Medical Oncology and volunteered to participate in the study will be included in the study.
You may qualify if:
- To be between the ages of 40-80 years,
- Volunteering to participate in the research,
- At least 15 months after breast cancer surgery,
- months after active breast cancer treatment (ie surgery/chemotherapy)
- Having no problem in reading and/or understanding the scales and being able to cooperate with the tests.
You may not qualify if:
- Presence of active infection,
- Having a neurological disease or other clinical diagnosis that may affect cognitive status,
- Having musculoskeletal and neurological disease, symptomatic heart disease, previous lung surgery and malignant disease that may affect exercise performance.
- Presence of unstable hypertension or diabetes mellitus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, State, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ebru Calik Kutukcu, PhD
Hacettepe University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 15, 2025
First Posted
February 20, 2025
Study Start
July 30, 2024
Primary Completion
May 29, 2025
Study Completion
September 15, 2025
Last Updated
December 16, 2025
Record last verified: 2025-12